Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Edderd who wrote (9601)	6/13/1998 6:02:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Ed, Read post 9368, 9384, and 9385. I think the numbers calculated in 9368 are valid and already show a turning of the tide. I agree with you that the Viagra fall out recovery will take some time. I may be overly optimistic but I can easily see 14,000+ by the end of July. What do you think will happen if Pfizer soon makes a release advising men on high blood pressure medications not to take Viagra? As the TUNA predicts, it will remove about 75% of the organic ED pool from Viagra use. I think that this will happen sooner than later since there is a huge liability issue hanging over Pfizer's head. Pfizer can make plenty of money on the rest of the ED pool including the psychogenics, and those merely desiring erectile enhancement (which I believe has accounted for over 1/2 their sales). Continued deaths from men with cardiovascular disease along with those on high blood pressure meds may eventually result in the FDA pulling Viagra altogether. That risk would be greatly reduced if Pfizer feses up to potential dangers of mixing Viagra with high blood pressure meds. Pfizer can either be greedy and stupid at the risk of losing all potential Viagra sales or they can be smart and conservative and cut their liabilities on the high blood pressure pool of Viagra users.